RevolKa Ltd. is a biotech company that uses AI to engineer novel proteins for therapeutic and industrial applications, focusing on drug discovery and development for rare diseases.

Rege Nephro Co., Ltd. is a clinical-stage biotech company developing treatments for kidney diseases, including Autosomal Dominant Polycystic Kidney Disease and Chronic Kidney Disease, using technology from Kyoto University's Center for iPS Cell Research and Application.